130 related articles for article (PubMed ID: 32390401)
1. The Role of Resolvin D1 in the Differential Diagnosis of the Cholangiocarcinoma and Benign Biliary Diseases.
Gül-Utku Ö; Karatay E; Ergül B; Kisa Ü; Erdin Z; Oğuz D
Clin Lab; 2020 May; 66(5):. PubMed ID: 32390401
[TBL] [Abstract][Full Text] [Related]
2. Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions.
Ince AT; Yıldız K; Baysal B; Danalıoğlu A; Kocaman O; Tozlu M; Gangarapu V; Sarbay Kemik A; Uysal Ö; Şentürk H
Turk J Gastroenterol; 2014 Apr; 25(2):162-9. PubMed ID: 25003676
[TBL] [Abstract][Full Text] [Related]
3. Bile-derived circulating extracellular miR-30d-5p and miR-92a-3p as potential biomarkers for cholangiocarcinoma.
Han HS; Kim MJ; Han JH; Yun J; Kim HK; Yang Y; Kim KB; Park SM
Hepatobiliary Pancreat Dis Int; 2020 Feb; 19(1):41-50. PubMed ID: 31784323
[TBL] [Abstract][Full Text] [Related]
4. Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy.
Leelawat K; Sakchinabut S; Narong S; Wannaprasert J
BMC Gastroenterol; 2009 Apr; 9():30. PubMed ID: 19405942
[TBL] [Abstract][Full Text] [Related]
5. High Bile Titer and High Bile to Serum Ratio of CYFRA 21 - 1 Reliably Discriminate Malignant Biliary Obstruction Caused by Cholangiocarcinoma.
Chen J; Liang J; Xu B; Liang J; Ma M; Wang Z; Zeng G; Xu Q; Liang L; Lai J; Huang L
J Gastrointest Cancer; 2024 Jun; 55(2):800-808. PubMed ID: 38280173
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP.
Park MS; Kim TK; Kim KW; Park SW; Lee JK; Kim JS; Lee JH; Kim KA; Kim AY; Kim PN; Lee MG; Ha HK
Radiology; 2004 Oct; 233(1):234-40. PubMed ID: 15333766
[TBL] [Abstract][Full Text] [Related]
7. Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases.
Wasenang W; Chaiyarit P; Proungvitaya S; Limpaiboon T
Clin Epigenetics; 2019 Mar; 11(1):39. PubMed ID: 30832707
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of pancreatobiliary cancer from benign biliary strictures using neutrophil gelatinase-associated lipocalin.
Budzynska A; Nowakowska-Dulawa E; Marek T; Boldys H; Nowak A; Hartleb M
J Physiol Pharmacol; 2013 Feb; 64(1):109-14. PubMed ID: 23568978
[TBL] [Abstract][Full Text] [Related]
9. Serum cathepsin B to cystatin C ratio as a potential marker for the diagnosis of cholangiocarcinoma.
Monsouvanh A; Proungvitaya T; Limpaiboon T; Wongkham C; Wongkham S; Luvira V; Proungvitaya S
Asian Pac J Cancer Prev; 2014; 15(21):9511-5. PubMed ID: 25422248
[TBL] [Abstract][Full Text] [Related]
10. Analysis of bile acid profile in plasma to differentiate cholangiocarcinoma from benign biliary diseases and healthy controls.
Zhang X; Yang Z; Shi Z; Zhu Z; Li C; Du Z; Zhang Y; Wang Z; Jiao Z; Tian X; Zhang J; Zhai W; Kan Q
J Steroid Biochem Mol Biol; 2021 Jan; 205():105775. PubMed ID: 33130021
[TBL] [Abstract][Full Text] [Related]
11. CA19-9 antigen levels can distinguish between benign and malignant pancreaticobiliary disease.
Morris-Stiff G; Teli M; Jardine N; Puntis MC
Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):620-6. PubMed ID: 20007080
[TBL] [Abstract][Full Text] [Related]
12. Serum Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) Level as a Potential Biomarker of Cholangiocarcinoma.
Tummanatsakun D; Proungvitaya T; Roytrakul S; Limpaiboon T; Wongkham S; Wongkham C; Silsirivanit A; Somintara O; Sangkhamanon S; Proungvitaya S
Biomolecules; 2019 Aug; 9(9):. PubMed ID: 31454981
[TBL] [Abstract][Full Text] [Related]
13. Total serum bile acid as a potential marker for the diagnosis of cholangiocarcinoma without jaundice.
Sombattheera S; Proungvitaya T; Limpaiboon T; Wongkham S; Wongkham C; Luvira V; Proungvitaya S
Asian Pac J Cancer Prev; 2015; 16(4):1367-70. PubMed ID: 25743800
[TBL] [Abstract][Full Text] [Related]
14. Characteristic Features of Cholangiocarcinoma Complicating Primary Sclerosing Cholangitis.
Ishii Y; Sasaki T; Serikawa M; Kobayashi K; Kamigaki M; Minami T; Okazaki A; Yukutake M; Ishigaki T; Kosaka K; Mouri T; Yoshimi S; Chayama K
Hepatogastroenterology; 2014 May; 61(131):567-73. PubMed ID: 26176037
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of the diagnostic value of Wisteria floribunda agglutinin-sialylated mucin1 and the prognostic role of mucin1 in human cholangiocarcinoma.
Tang Z; Yang Y; Wang X; Meng W; Li X
BMJ Open; 2019 Jan; 9(1):e021693. PubMed ID: 30700476
[TBL] [Abstract][Full Text] [Related]
16. Transpapillary biliary biopsy for malignant biliary strictures: comparison between cholangiocarcinoma and pancreatic cancer.
Chen WM; Wei KL; Chen YS; Chang PJ; Tung SY; Chang TS; Huang HC; Shen CH; Hsieh YY; Wu CS
World J Surg Oncol; 2016 May; 14():140. PubMed ID: 27142076
[TBL] [Abstract][Full Text] [Related]
17. The Detection of Cholangiocarcinoma in Primary Sclerosing Cholangitis Patients: Single Center Experience.
Kuzu UB; Ödemiş B; Suna N; Yıldız H; Parlak E; Dişibeyaz S; Torun S; Akpınar MY; Coşkun O; Turhan N; Yüksel M; Kayaçetin E
J Gastrointest Cancer; 2016 Mar; 47(1):8-14. PubMed ID: 26537791
[TBL] [Abstract][Full Text] [Related]
18. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.
Scarlett CJ; Saxby AJ; Nielsen A; Bell C; Samra JS; Hugh T; Baxter RC; Smith RC
Hepatology; 2006 Sep; 44(3):658-66. PubMed ID: 16941699
[TBL] [Abstract][Full Text] [Related]
19. Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a preliminary case-control study.
Lumachi F; Lo Re G; Tozzoli R; D'Aurizio F; Facomer F; Chiara GB; Basso SM
Anticancer Res; 2014 Nov; 34(11):6663-7. PubMed ID: 25368272
[TBL] [Abstract][Full Text] [Related]
20. Volatile organic compounds in bile for early diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis: a pilot study.
Navaneethan U; Parsi MA; Lourdusamy V; Bhatt A; Gutierrez NG; Grove D; Sanaka MR; Hammel JP; Stevens T; Vargo JJ; Dweik RA
Gastrointest Endosc; 2015 Apr; 81(4):943-9.e1. PubMed ID: 25500329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
